Old Mission Capital LLC Aclaris Therapeutics, Inc. Transaction History

Old Mission Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$9.74 - $17.92 $152,557 - $280,680	-15,663 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$12.27 - $18.49 $192,185 - $289,608	15,663 New	15,663 $228,000
Q3 2021 Nov 12, 2021	SELL	$13.38 - $18.8 $499,528 - $701,879	-37,334 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$17.08 - $29.6 $637,664 - $1.11 Million	37,334 New	37,334 $656,000
Q3 2020 Nov 16, 2020	SELL	$1.5 - $2.71 $142,200 - $256,908	-94,800 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$1.04 - $1.73 $98,592 - $164,004	94,800 New	94,800 $154,000

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $193M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Old Mission Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Old Mission Capital LLC with notifications on news.